Search

everythinglearnresearchcommunity

for

Search:↓

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Skin reactions from cancer treatments might predict how well the treatments work.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

UVB radiation changes the levels of certain microRNAs in skin cells, which may affect cell survival and hair growth.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Ginsenoside Rg4 from ginseng may help hair growth by activating certain cell signals.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Propylthiouracil can cause hair loss, reduced sweating, and nail issues, but stopping the drug can reverse hair and nail problems.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.